Novel Stratification of Mortality Risk by Kidney Disease Stage.

CONCLUSION: IMRS is a strong predictor of mortality in patients with CKD and is robustly complementary to CKD stage in refining risk prediction. Given the universal availability and low cost of the CBC and BMP, IMRS may be of a substantial value in CKD risk assessment and management.
PMID: 26812216 [PubMed - as supplied by publisher]

Source: American Journal of Nephrology - January 27, 2016 Category: Urology & Nephrology Authors: Rassa AC, Horne BD, McCubrey RO, Bair TL, Muhlestein JB, Morris DR, Anderson JL Tags: Am J Nephrol Source Type: research